Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2023-08-28 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
太平洋证券股份有限公司关于华蓝集团股份公司使用部分闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from Pacific Securities Co., Ltd. regarding the use of part of the idle raised funds by Hualan Group Co., Ltd. for cash management. It includes specifics about the fundraising, usage plans, investment risks, board and supervisory approvals, and independent director opinions. The document references regulatory guidelines and approvals but does not contain financial statements or quarterly/yearly financial results. It is a formal verification and opinion report related to the use of raised funds, which aligns with an Audit Report / Information filing rather than an Annual Report or Interim Report. The document length is 4266 characters, which is relatively short but contains substantive content beyond a mere announcement. Therefore, it is best classified as an Audit Report / Information (AR). FY 2023
2023-08-28 Chinese
关于第四届董事会第十七次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of an agenda item for the 17th meeting of the 4th board of directors of 华蓝集团股份公司. It discusses the anticipated increase in related party transactions for 2023 and confirms compliance with relevant laws and regulations. There is no financial data, no report attached or referenced as published, and no indication of a full report or announcement of voting results. The document is related to board/management information about internal governance and approvals. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board meeting matters, not a full report or announcement.
2023-08-28 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '华蓝集团股份公司2023 年半年度报告摘要' which translates to 'Hualan Group Co., Ltd. 2023 Semi-Annual Report Summary'. It contains financial data for the half-year period, including revenue, net profit, cash flow, earnings per share, and asset information. It also includes shareholder information and notes on board meetings and important matters during the period. The document is about 2791 characters long, which is relatively short but contains substantive financial data and analysis for a half-year period. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial statements and substantive financial data. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-28 Chinese
华蓝集团股份公司董事会关于2023年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from the board of directors of 华蓝集团股份公司 regarding the storage and usage of funds raised in the first half of 2023. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange concerning the management and use of raised funds. The content includes specifics on the amount raised, usage, balances, management systems, supervisory agreements, and detailed tables on fund usage and project progress. The document is 7570 characters long, which is substantial and contains actual financial data and analysis related to fundraising activities and their management. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an announcement of a report publication, nor a general regulatory filing, but a substantive report on fundraising usage and management.
2023-08-28 Chinese
关于召开2023年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2023 second extraordinary general meeting (临时股东大会) of Huazhou Group Co., Ltd. It includes information about the meeting date, time, location, voting procedures (both in-person and online), agenda items to be discussed and voted on, registration details, and proxy voting instructions. The document does not contain financial statements or results but is a formal announcement to shareholders about the meeting and how to participate and vote on proposals. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document is not an Annual Report, Earnings Release, or any other financial report, nor is it a simple announcement of a report publication. Therefore, the correct classification is PSI with high confidence.
2023-08-28 Chinese
关于2023年半年度计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the impairment provisions for the half-year period ending June 30, 2023. It details the amounts of impairment provisions made, the accounting policies applied, and the impact on the company's profit. The document is relatively short (2706 characters) and focuses on the impairment provision announcement rather than providing a full interim financial report with comprehensive financial statements. It does not contain full financial statements or substantive financial data typical of an Interim/Quarterly Report (IR). Instead, it is a regulatory announcement about impairment provisions, which fits best under Regulatory Filings (RNS) as it does not meet the criteria for a full financial report and is not merely a report publication announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-08-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.